MedGen 

$0.000030
2
+$0.00+0%Thursday 20:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.00003
52W Low
0.000001
Volume
33,334
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Aug 26Expected
Q3 2012
Q4 2012
Q1 2013
Q2 2013
0
0
0
0
Expected EPS
N/A
Actual EPS
0

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a major player in the pharmaceutical industry, directly competing with MedGen in the development and marketing of medical and healthcare products.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson offers a broad range of health products, competing with MedGen in multiple healthcare sectors.
Merck
MRK
Mkt Cap356.01B
Merck operates in the pharmaceutical industry, producing medicines and vaccines that compete with MedGen's product offerings.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie competes in the pharmaceutical sector, particularly in areas that overlap with MedGen's therapeutic focus.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly and Company is a competitor in the pharmaceutical field, developing drugs that can be in direct competition with MedGen's products.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline is involved in the creation and distribution of drugs and healthcare services, competing with MedGen in similar markets.
Novartis
NVS
Mkt Cap268B
Novartis is known for its innovative medicines and directly competes with MedGen in the pharmaceuticals market.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb is a global biopharmaceutical company whose products compete with MedGen's in the healthcare market.
Sanofi
SNY
Mkt Cap95.65B
Sanofi operates globally in the pharmaceutical sector, offering products that compete with MedGen's healthcare solutions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap46.1B
Teva Pharmaceutical Industries specializes in generic and specialty medicines, competing with MedGen in various therapeutic areas.

About

On June 25, 2020, MedGen, Inc. acquired 9430075 Canada Ltd. through a reverse merger transaction. Founded in 2015 and based in Winnipeg, Canada, 9430075 Canada Ltd. manages a digital health and wellness platform. This platform serves two primary functions: it assists individuals in finding vital health information and referrals, and it allows health and wellness professionals to directly engage with clients.
Show More
CEO
Adir Iakya
Employees
3
Country
Canada
ISIN
US58436J1007

Listings

0 Comments

Share your thoughts

FAQs

What is MedGen stock price today?▼
The current price of MDIN is $0.00 USD — it has increased by +0% in the past 24 hours. Watch MedGen stock price performance more closely on the chart.
What is MedGen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange MedGen stocks are traded under the ticker MDIN.
Is MedGen stock price growing?▼
MDIN stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year MedGen has showed a +0% increase.
What were MedGen earnings last quarter?▼
MDIN earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does MedGen have?▼
As of November 2, 2026, the company has 3 employees.
In which sector is MedGen located?▼
MedGen operates in the Health & Wellness sector.
When did MedGen complete a stock split?▼
The last stock split for MedGen was on June 2, 2008 with a ratio of 1:200.
Where is MedGen headquartered?▼
MedGen is headquartered in Winnipeg, Canada.